| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 16, 2005
Accepted on January 20, 2006
Division of Endocrinology and Metabolism, Department of Internal Medicine; Department of Anatomy, Pharmacology and Forensic Medicine; University of Turin, ITALY
* To whom correspondence should be addressed. E-mail: ezio.ghigo{at}unito.it.
Context: Cortistatin binds all somatostatin receptor subtypes but has also particular central actions; moreover a specific cortistatin receptor has also been discovered.
Objective: We compared the endocrine effects of cortistatin-17 with those of somatostatin-14 in patients with acromegaly (ACRO) or prolactinoma (PRLOMA). Normal subjects (NS) were studied as control group.
Design: All subjects underwent the following tests: 1) saline; 2) somatostatin-14 (2.0 µg/kg/h i.v. 0'-120'); 3) cortistatin-17 (2.0 µg/kg/h i.v. 0'-120') infusion.
Results: Cortistatin-17 and somatostatin-14 inhibited GH secretion to the same extent in ACRO (P < 0.05) and NS (P < 0.01). Cortistatin-17 and somatostatin-14 inhibited PRL secretion in PRLOMA (P < 0.05), to some extent in ACRO (p =NS) but not in NS. Insulin secretion was inhibited by both cortistatin-17 and somatostatin-14 to the same extent in all groups (P < 0.05).
Conclusions: Cortistatin-17 and somatostatin-14 display the same effects on GH, PRL and insulin secretion in patients with acromegaly or prolactinoma.
This article has been cited by other articles:
![]() |
R. M. Luque and R. D. Kineman Gender-Dependent Role of Endogenous Somatostatin in Regulating Growth Hormone-Axis Function in Mice Endocrinology, December 1, 2007; 148(12): 5998 - 6006. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Giordano, A Picu, L Bonelli, F Broglio, F Prodam, S Grottoli, G Muccioli, E Ghigo, and E Arvat The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's disease Eur. J. Endocrinol., October 1, 2007; 157(4): 393 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rubinfeld, M. Hadani, G. Barkai, J. E. Taylor, M. D. Culler, and I. Shimon Cortistatin Inhibits Growth Hormone Release from Human Fetal and Adenoma Pituitary Cells and Prolactin Secretion from Cultured Prolactinomas J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2257 - 2263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |